March 11, 2013 at 08:55 AM EDT
Catalent Pharma Expands in China with Two Deals
Catalent Pharma Solutions, a New Jersey company, announced two transactions that will increase its presence in China. First, Catalent will acquire majority share of Zhejiang Jiang Yuan Tang Biotechnology Co., a Haining maker of nutritional softgel products for China and other Asia Pacific markets. And second, Catalent formed a JV with ShangPharma that will provide supplies of drugs for clinical trials. Catalent is involved in drug delivery systems, including soft gels, and it also provides clinical and commercial supplies of drugs world-wide. More details.... Share this with colleagues: // //  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here